We are live on
!
Find out more
EWM
Essex Woodlands Management Portfolio holdings
AUM
$254M
1-Year Est. Return
4.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$130M
AUM Growth
–
Cap. Flow
+$132M
Cap. Flow
% of AUM
101.34%
Top 10 Holdings %
Top 10 Hldgs %
99.99%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$63.3M |
| 2 |
ACUR
Acura Pharmaceuticals
ACUR
|
+$23.3M |
| 3 |
ELGX
Endologix Inc
ELGX
|
+$16.5M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$14M |
| 5 |
Alaunos Therapeutics
TCRT
|
+$5.12M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $67.9M | 52.05% |
+3,150,000
| New | +$63.3M |
|
|
ACUR
2
DELISTED
Acura Pharmaceuticals
ACUR
| $18.7M | 14.34% |
+2,058,977
| New | +$23.3M |
|
|
ELGX
3
DELISTED
Endologix Inc
ELGX
| $15.5M | 11.86% |
+116,543
| New | +$16.5M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $13.1M | 10.07% |
+5,815,940
| New | +$14M |
|
|
5
Alaunos Therapeutics
TCRT
$4.86M
| $5.41M | 4.15% |
+18,433
| New | +$5.12M |
|
6
MediciNova
MNOV
$66M
| $3.08M | 2.36% |
+1,170,370
| New | +$3.45M |
|
|
SLTM
7
DELISTED
SOLTA MED INC (DE)
SLTM
| $3.03M | 2.32% |
+1,330,219
| New | +$2.81M |
|
|
CO
8
DELISTED
Global Cord Blood Corporation
CO
| $2.92M | 2.23% |
+1,037,690
| New | +$2.96M |
|
9
Curis
CRIS
$7.83M
| $745K | 0.57% |
+117
| New | +$827K |
|
|
ECTE
10
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $31K | 0.02% |
+12,319
| New | +$64.6K |
|
|
PTN
11
Palatin Technologies
PTN
$13.8M
| $14K | 0.01% |
+19
| New | +$14.6K |
|
Similar funds
1W
TSM
LI
LIA
IGM
WWM
MWM
LRIC
Essex Woodlands Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Essex Woodlands Management, which disclosed 11 positions worth $130M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Abiomed Inc: 3,150,000 shares worth $67.9M.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets.
- Essex Woodlands Management's largest Q2 2013 buy was Abiomed Inc: 3,150,000 shares worth $67.9M.
- Essex Woodlands Management's ten largest holdings make up 100% of its $130M portfolio in Q2 2013.
- Essex Woodlands Management disclosed 11 positions in Q2 2013, its first 13F filing on record.
Based on Essex Woodlands Management's 13F filing for Q2 2013, filed 14 Aug 2013.